Akari Therapeutics reported net income of -$0.00B for the quarter ended Jun 2026. This income statement covers 44 quarters of results from Dec 2011 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2011 | Dec2012 | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Dec2016 | Jun2017 | Dec2017 | Jun2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Jun2021 | Dec2021 | Jun2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 3.39B | 3.16B | 3.85B | 7.44B | 7.47B | 10.12B | 10.13B | 9.79B | 15.97B | 16.14B | 24.29B | 23.89B | 57.75B | 65.23B | 65.23B | 67.33B | 118.76B | 140.03B | ||||||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||||||||||||
| Amortization - Intangibles | ||||||||||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | ||||||||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.10B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | ||||||||||||||||||||||||||
| Restructuring CostsRestructuring | 0.00B | 0.00B | 0.00B | |||||||||||||||||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | -0.00B | 0.01B | ||||||||||||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 0.00B | 0.01B | 0.00B | 0.01B | 0.00B | 0.00B | 0.00B | 0.01B | 0.01B | 0.01B | 0.00B | 0.11B | 0.00B | 0.00B | 0.00B | 0.00B | 0.02B | 0.00B | ||||||||||||||||||||||||||
| Operating IncomeOp. Inc | -0.00B | -0.01B | -0.00B | -0.01B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.00B | -0.11B | -0.00B | -0.00B | -0.01B | -0.00B | -0.02B | -0.00B | ||||||||||||||||||||||||||
| EBIT | -0.00B | -0.01B | -0.00B | -0.01B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.00B | -0.11B | -0.00B | -0.00B | -0.01B | -0.00B | -0.02B | -0.00B | ||||||||||||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.00B | 0.00B | 0.03B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.00B | 0.00B | -0.00B | 0.00B | 0.01B | 0.00B | -0.00B | 0.00B | 0.00B | -0.00B | 0.00B | -0.03B | -0.00B | 0.00B | -0.00B | -0.00B | 0.00B | -0.00B | ||||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | 0.00B | 0.00B | -0.00B | 0.00B | 0.01B | 0.00B | -0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | -0.00B | 0.00B | -0.00B | -0.00B | 0.00B | -0.00B | ||||||||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||||||||||||
| EBT | -0.00B | -0.01B | -0.00B | -0.01B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.00B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.02B | -0.00B | ||||||||||||||||||||||||||
| Tax ProvisionsTaxes | -0.00B | 0.00B | -0.00B | |||||||||||||||||||||||||||||||||||||||||
| Profit After TaxPAT | 0.00B | -0.01B | -0.00B | -0.01B | 0.00B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.00B | -0.14B | -0.00B | -0.00B | -0.01B | -0.00B | -0.01B | -0.00B | ||||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -0.00B | -0.01B | -0.00B | -0.01B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.00B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.00B | ||||||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -0.00B | -0.01B | -0.00B | -0.01B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.00B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.00B | ||||||||||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -0.00B | -0.01B | -0.00B | -0.01B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.00B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.00B | ||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -0.00B | -0.01B | -0.00B | -0.01B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.00B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.00B | ||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||||||||
| EPS (Basic) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||||||||
| EPS (Diluted) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||||||||
| Shares Outstanding | 3.34B | 3.16B | 3.16B | 4.29B | 4.29B | 6.24B | 7.47B | 10.12B | 10.12B | 9.79B | 13.45B | 16.14B | 24.39B | 23.89B | 54.59B | 62.94B | 65.33B | 67.33B | 118.76B | 143.32B | ||||||||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 1.83B | 3.16B | 3.16B | 4.29B | 4.29B | 6.24B | 7.57B | 10.12B | 10.12B | 9.79B | 13.45B | 18.84B | 24.39B | 23.89B | 54.59B | 62.94B | 65.33B | 67.33B | 118.76B | 143.32B | ||||||||||||||||||||||||
| EBITDA | -0.00B | -0.01B | -0.00B | -0.01B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.00B | -0.11B | -0.00B | -0.00B | -0.01B | -0.00B | -0.02B | -0.00B | ||||||||||||||||||||||||||
| Interest ExpensesInt Expense | 0.00B | 0.00B | 0.03B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||||||||||||||||||||||||
| Tax Rate | 14.53 | -1.63 | 5.61 |